Evidence map›Paper›PMID 42434427›Full record

ArticleOxford open immunology2026

Structural homology of HHV-6B epitopes as candidates for molecular mimicry triggers of the onset type one diabetes mellitus.

McKay Jones, Julio C Facelli

Abstract read
In one paragraph

Article in Oxford open immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

McKay JonesUtah Valley University, Orem, UT, United States.
Julio C FacelliDepartment of Biomedical Informatics, Spencer Fox Eccles School of Medicine, The University of UT, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0003-1449-477X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To study whether HHV-6B can act as a molecular mimic to trigger onset of Type One Diabetes Mellitus (T1DM) by assessing structural and binding similarities between HHV-6B derived epitopes and T1DM autoantigen derived epitopes. Methods: Epitope peptide structures and their interactions with T1DM autoantigens were modeled using Boltz-2, a state-of-the-art artificial intelligence protein structure prediction method. Results: Several HHV-6B epitopes studied here demonstrated high structural alignment with T1DM antigen epitopes, but even when structural homology was lacking, in multiple cases the HHV-6B and T1DM epitopes fit into the same binding region of the corresponding HLA molecules, suggesting a plausible structural basis for T cell cross-reactivity. These findings support the hypothesis that HHV-6B may act as a molecular mimic contributing to autoimmune responses in individuals genetically susceptible to T1DM. Conclusion: This study demonstrates that structural modeling is a useful tool for identifying potential mimicry candidates that sequence-based methods may not find, underscoring the importance of integrating structure-based modeling, including docking, into molecular mimicry prediction pipelines for identifying potential epitopes for

Indexed as

autoinmunity, roseolaHHV-6Bmolecular mimicryprotein structure predictionstructural homologyT1DM

Identifiers

PMID42434427
PMCPMC13350986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.